Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease

Published:2022-08-01 Issue:8 Volume:7 Page:794
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Gue Ying X.¹,Gorog Diana A.²³,Lip Gregory Y. H.¹⁴

Affiliation:

1. Liverpool Centre for Cardiovascular Science, Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, United Kingdom

2. School of Life and Medical Sciences, Postgraduate Medical School, University of Hertfordshire, Hertfordshire, United Kingdom

3. Faculty of Medicine, National Heart & Lung Institute, Imperial College, London, United Kingdom

4. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2793526/jamacardiology_gue_2022_ic_220005_1659374756.87133.pdf

Reference10 articles.

1. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.;Knuuti;Eur Heart J,2020

2. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary.;Chao;Thromb Haemost,2022

3. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: a position paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society.;Gorog;Europace,2022

4. Rivaroxaban monotherapy vs combination therapy with antiplatelets on total thrombotic and bleeding events in atrial fibrillation with stable coronary artery disease: a post hoc secondary analysis of the AFIRE trial.;Naito;JAMA Cardiol

5. Aspirin for primary and secondary prevention of cardiovascular disease: time to stop?;Cleland;Thromb Haemost,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic management in atrial fibrillation patients following percutaneous coronary intervention: A clinical review;Journal of Arrhythmia;2024-08-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3